Steven Cobourn
Direttore Finanziario/CFO presso NEXTCURE, INC.
Patrimonio netto: - $ in data 30/04/2024
Provenienza dei contatti di primo grado di Steven Cobourn
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 23 | |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
| Public Company | Biotechnology | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Steven Cobourn tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Chief Administrative Officer Corporate Officer/Principal Corporate Officer/Principal | |
Otsuka Pharmaceutical Co., Ltd.
 Otsuka Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Otsuka Pharmaceutical Co. Ltd. engages in the manufacturing, distributing, exporting, and importing of pharmaceuticals, clinical testing equipment, medical device and equipment, food products, cosmetics, and other related products. Its operations are carried out through the following business divisions: Pharmaceutical Business and Nutraceutical Business. The Pharmaceutical Business division engages in the manufacture and sale of pharmaceutical products for the diagnosis and treatment of diseases. The Nutraceutical Business division provides nutritional products, cosmetics and medicines that support day-to-day health maintenance and improvement. The company was founded on August 10, 1964 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Yale University | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Chairman Director/Board Member Chief Executive Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ARVINAS, INC. | Biotechnology | Chief Executive Officer Director/Board Member Chief Executive Officer | |
| GRITSTONE BIO, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| INTERMUNE INC | Biotechnology | Director/Board Member Founder | |
| PIERIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chairman | |
| ONCORUS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Yale School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Otsuka America, Inc.
 Otsuka America, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America, Inc. operates as a holding company for Otsuka America Pharmaceutical. Its primary objective is to bring products to the U.S. market developed by Otsuka America Pharmaceutical's Japanese parent company, Otsuka Pharmaceutical Co., Ltd. Those products center on treating neurological and cardiovascular diseases. The company was founded in 1989 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of Toronto | College/University | Undergraduate Degree Graduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| University of California, Davis | College/University | Undergraduate Degree Doctorate Degree | |
| GENVEC INC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
| The University of Connecticut School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| HBM HEALTHCARE INVESTMENTS AG | Investment Managers | Director/Board Member Director/Board Member | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Sales & Marketing | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Kalobios Pharmaceuticals, Inc. | Corporate Officer/Principal | ||
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CURIS, INC. | Biotechnology | Director/Board Member | |
NiKang Therapeutics, Inc.
 NiKang Therapeutics, Inc. BiotechnologyHealth Technology NiKang Therapeutics, Inc. operates as biotechnology company. It focuses on developing novel small molecule oncology drug discovery. The company was founded by Zhenhai Gao and is headquartered in Wilmington, DE. | Biotechnology | Director/Board Member | |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Stritch School of Medicine | College/University | Doctorate Degree | |
| The Johns Hopkins University | College/University | Doctorate Degree | |
| HUMANIGEN, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| University of Illinois | College/University | Undergraduate Degree | |
| VIKING THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Miscellaneous Commercial Services | Director/Board Member | |
| The University of Alabama at Birmingham | College/University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 43 |
| Irlanda | 3 |
| Giappone | 2 |
| Austria | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 34 |
| Consumer Services | 12 |
| Commercial Services | 3 |
| Technology Services | 2 |
| Finance | 2 |
Posizioni
| Director/Board Member | 237 |
| Corporate Officer/Principal | 83 |
| Independent Dir/Board Member | 80 |
| Chairman | 50 |
| Undergraduate Degree | 33 |
Contatti più connessi
| Insiders | |
|---|---|
| Chau Khuong | 38 |
| Elaine Jones | 37 |
| David Kabakoff | 30 |
| Timothy Shannon | 28 |
| Briggs Morrison | 26 |
| Ann Hanham | 26 |
| Paul Freiman | 25 |
| Stephen Webster | 23 |
| Donald Hayden | 23 |
| Mark Altmeyer | 16 |
| Michael Richman | 16 |
| Judith Li | 15 |
| Ellen Feigal | 15 |
| Mark Glickman | 14 |
| Garry Nicholson | 14 |
- Borsa valori
- Insiders
- Steven Cobourn
- Connessioni Società
